20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Role of [1,1'-Bis(di-cyclohexylphosphino)ferrocene]dichloropalladium(II) in Pharmaceutical Synthesis

The pharmaceutical industry constantly seeks efficient and reliable methods to synthesize complex drug molecules. At the heart of many modern synthetic pathways lie palladium-catalyzed cross-coupling reactions, and a key enabler for these transformations is high-purity metal catalysts. This article highlights the significant contribution of [1,1'-Bis(di-cyclohexylphosphino)ferrocene]dichloropalladium(II) (CAS: 917511-90-1) to pharmaceutical synthesis, emphasizing its properties and the advantages of sourcing it from specialized manufacturers.

A Cornerstone in Modern Drug Discovery

[1,1'-Bis(di-cyclohexylphosphino)ferrocene]dichloropalladium(II) is a sophisticated palladium catalyst recognized for its efficacy in forging crucial carbon-carbon (C-C) and carbon-nitrogen (C-N) bonds. These types of bond formations are fundamental to constructing the intricate scaffolds of many pharmaceutical compounds. The catalyst's structure, incorporating the robust ferrocene framework and bulky phosphine ligands, provides exceptional stability and reactivity, allowing for the successful coupling of diverse substrates, including challenging ones.

Its typical appearance as an orange to red crystalline powder, with a specified minimum purity of 97% and a significant Palladium content (≥14%), assures researchers and production chemists of its potent catalytic capabilities. This makes it an indispensable tool for the synthesis of intermediates and final active pharmaceutical ingredients (APIs).

Key Applications in Pharmaceutical Synthesis

The versatility of [1,1'-Bis(di-cyclohexylphosphino)ferrocene]dichloropalladium(II) makes it applicable in several critical reactions within pharmaceutical R&D and manufacturing:

  • Suzuki-Miyaura Coupling: Widely used for synthesizing biaryl structures common in many drug molecules.
  • Buchwald-Hartwig Amination: Essential for introducing amine functionalities, vital for a vast number of therapeutic agents.
  • Heck Reaction: Useful for functionalizing alkenes and building complex carbon skeletons.
  • Sonogashira Coupling: Enables the introduction of alkynyl groups, which can serve as versatile handles for further functionalization.

These reactions, when catalyzed by high-quality palladium complexes like this one, offer high yields, excellent selectivity, and often proceed under milder conditions, reducing energy consumption and the generation of unwanted byproducts. This efficiency is paramount in the pharmaceutical sector where cost-effectiveness and environmental sustainability are increasingly important.

The Benefit of Partnering with a China Manufacturer

For pharmaceutical companies and contract research organizations (CROs), securing a reliable and cost-effective supply of essential reagents is vital. When considering the purchase of [1,1'-Bis(di-cyclohexylphosphino)ferrocene]dichloropalladium(II), partnering with a reputable manufacturer in China offers compelling advantages. Chinese manufacturers often leverage advanced production technologies and economies of scale, enabling them to offer high-purity chemicals at highly competitive prices. This allows pharmaceutical companies to significantly reduce their raw material costs without compromising the quality essential for drug development and manufacturing.

We, as a dedicated manufacturer, pride ourselves on supplying [1,1'-Bis(di-cyclohexylphosphino)ferrocene]dichloropalladium(II) that meets rigorous international standards. Our commitment to quality assurance and consistent production ensures that your supply chain remains robust and dependable. We encourage pharmaceutical professionals to buy this catalyst from us and to request a quote to explore our competitive pricing and discuss bulk order requirements.

In conclusion, [1,1'-Bis(di-cyclohexylphosphino)ferrocene]dichloropalladium(II) is more than just a reagent; it's a critical enabler of innovation in pharmaceutical synthesis. Its proven effectiveness in forming essential C-C and C-N bonds, coupled with the benefits of direct sourcing from a quality-focused China manufacturer, makes it an intelligent choice for any organization involved in drug discovery and development. Contact us today to secure your supply and drive your pharmaceutical projects forward.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Cost-Effective Procurement of Palladium Catalysts: A Focus on [1,1'-Bis(di-cyclohexylphosphino)ferrocene]dichloropalladium(II)

Next: Exploring Novel Material Synthesis with [1,1'-Bis(di-cyclohexylphosphino)ferrocene]dichloropalladium(II)

All Rights Reserved